首页> 美国卫生研究院文献>Annals of Surgery >Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens.
【2h】

Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens.

机译:肛门内括约肌内注射肉毒杆菌毒素治疗慢性肛裂:两种不同剂量方案的长期疗效。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: To investigate the effects of two different dosage regimens of botulinum toxin to induce healing in patients with idiopathic anal fissure. SUMMARY BACKGROUND DATA: Chronic anal fissure is maintained by contraction of the internal anal sphincter. Sphincterotomy, which is successful in 85% to 95% of patients, permanently weakens the sphincter and therefore might be associated with anal deformity and incontinence. METHODS: Fifty-seven consecutive outpatients were evaluated. Type A botulinum toxin was injected into the internal anal sphincter. RESULTS: Patients were divided into two treatment groups based on the number of botulinum toxin units injected. Patients in the first group were treated with 15 units and retreated with 20 units. Patients in the second group were treated with 20 units and retreated with 25 units. Two months after treatment, 10 patients in the first group and 23 patients in the second group had a healing scar. Symptomatic improvement was observed in 13 patients in the first group and in 24 patients in the second group. Statistical analysis showed that resting anal pressure varied from baseline values as a function of treatment; in contrast, the treatment had no effect on maximum voluntary pressure. Long-term healing was achieved in 13 patients in the first group and in all patients in the second group who underwent a complete treatment. CONCLUSIONS: Botulinum toxin is safe and effective in the treatment of anal fissure. It is less expensive and easier to perform than surgical treatment. No adverse effects resulted from injections of the toxin. The higher dosage is effective in producing long-term healing without complications.
机译:目的:探讨两种不同剂量肉毒杆菌毒素疗法对特发性肛裂患者愈合的影响。发明内容背景数据:通过肛门内括约肌的收缩来维持慢性肛裂。括约肌切开术在85%至95%的患者中成功,可永久削弱括约肌,因此可能与肛门畸形和大小便失禁有关。方法:对57名连续的门诊病人进行了评估。将A型肉毒毒素注入肛门内括约肌。结果:根据注射的肉毒杆菌毒素单位数将患者分为两个治疗组。第一组患者用15个单位治疗,再用20个单位治疗。第二组患者接受20单位治疗,再接受25单位治疗。治疗后两个月,第一组有10例患者,第二组有23例患者有愈合疤痕。在第一组的13例患者和第二组的24例患者中观察到症状改善。统计分析表明,静息肛门压力与基线值之间存在差异,取决于治疗方法。相反,治疗对最大自愿压力没有影响。第一组中的13例患者和第二组中所有接受了完整治疗的患者均实现了长期愈合。结论:肉毒杆菌毒素治疗肛裂是安全有效的。与外科治疗相比,它更便宜且更容易执行。注射毒素没有引起不利影响。较高剂量可有效地产生长期治愈而无并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号